Insider Trading & Ownership - LAVA Therapeutics NV (LVTX)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for LAVA Therapeutics NV

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing

Ownership		2025-04-08
6:19 pm		N/A
N/A		LAVA Therapeutics NVLVTXCooperatieve Gilde Healthcare IV U.A.
Gilde Healthcare IV Management B.V.
Gilde Healthcare Holding B.V.
10% Owner		0$05,421,170
(Direct)		View
2025-02-13
Option Award		2025-02-18
8:15 pm		N/A
2035-02-12		LAVA Therapeutics NVLVTXWILSON KAREN J
Director		33,390$033,390
(Direct)		View
2025-02-13
Option Award		2025-02-18
8:15 pm		N/A
2035-02-12		LAVA Therapeutics NVLVTXWadlinger Mary E.
Director		33,390$033,390
(Direct)		View
2025-02-13
Option Award		2025-02-18
8:15 pm		N/A
2035-02-12		LAVA Therapeutics NVLVTXNoble James
Director		33,390$033,390
(Direct)		View
2025-02-13
Option Award		2025-02-18
8:15 pm		N/A
2035-02-12		LAVA Therapeutics NVLVTXKiener Peter A
Director		33,390$033,390
(Direct)		View
2025-02-13
Option Award		2025-02-18
8:15 pm		N/A
2035-02-12		LAVA Therapeutics NVLVTXBackstrom Jay T.
Director		33,390$033,390
(Direct)		View
2025-02-13
Option Award		2025-02-18
8:15 pm		N/A
2035-02-12		LAVA Therapeutics NVLVTXDhingra Kapil
Director		33,390$033,390
(Direct)		View
2025-02-13
Option Award		2025-02-18
8:15 pm		N/A
2035-03-12		LAVA Therapeutics NVLVTXPowell Fred M
Chief Financial Officer		124,700$0124,700
(Direct)		View
2025-02-13
Option Award		2025-02-18
8:15 pm		N/A
2035-03-12		LAVA Therapeutics NVLVTXMorris Charles Q
Chief Medical Officer		130,850$0130,850
(Direct)		View
2025-02-13
Option Award		2025-02-18
8:15 pm		N/A
2035-02-12		LAVA Therapeutics NVLVTXOliger Christy J.
Director		33,390$033,390
(Direct)		View
2025-02-13
Option Award		2025-02-18
8:15 pm		N/A
2035-03-12		LAVA Therapeutics NVLVTXHURLY STEPHEN A
Chief Executive Officer		335,100$0335,100
(Direct)		View

Ownership		2025-02-06
7:29 pm		N/A
N/A		LAVA Therapeutics NVLVTXVersant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner		0$04,587,837
(Direct)		View

Ownership		2025-01-02
09:35 am		N/A
N/A		LAVA Therapeutics NVLVTXWILSON KAREN J
Director		0$0107,651
(Direct)		View

Ownership		2025-01-02
09:34 am		N/A
2033-03-09		LAVA Therapeutics NVLVTXWadlinger Mary E.
Director		0$053,390
(Direct)		View

Ownership		2025-01-02
09:32 am		N/A
2033-03-09		LAVA Therapeutics NVLVTXOliger Christy J.
Director		0$053,390
(Direct)		View

Ownership		2025-01-02
09:31 am		N/A
2032-12-22		LAVA Therapeutics NVLVTXNoble James
Director		0$073,390
(Direct)		View

Ownership		2025-01-02
09:29 am		N/A
2033-03-09		LAVA Therapeutics NVLVTXKiener Peter A
Director		0$053,390
(Direct)		View

Ownership		2025-01-02
09:28 am		N/A
2032-12-22		LAVA Therapeutics NVLVTXBackstrom Jay T.
Director		0$073,390
(Direct)		View

Ownership		2025-01-02
09:26 am		N/A
N/A		LAVA Therapeutics NVLVTXDhingra Kapil
Director		0$0311,130
(Direct)		View

Ownership		2025-01-02
09:21 am		N/A
2033-02-05		LAVA Therapeutics NVLVTXMorris Charles Q
Chief Medical Officer		0$0370,400
(Direct)		View

Ownership		2025-01-02
09:20 am		N/A
N/A		LAVA Therapeutics NVLVTXPowell Fred M
Chief Financial Officer		0$0380,950
(Direct)		View

Ownership		2025-01-02
09:19 am		N/A
N/A		LAVA Therapeutics NVLVTXHURLY STEPHEN A
Chief Executive Officer		0$02,152,963
(Direct)		View